Long-term Kidney Disease Outcomes in Fibrillary Glomerulonephritis: A Case Series of 27 Patients
Vincent Javaugue(Université de Poitiers), Frank Bridoux(Université de Poitiers), Alexandre Karras(Délégation Paris 5), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), François Glowacki(Centre National de la Recherche Scientifique), Pièrre Aucouturier(Sorbonne Université), Jean‐Michel Goujon(Centre Hospitalier Universitaire de Poitiers), Brigitte McGregor(Lyon 1 Université), Corinne Lacombe(Université de Poitiers), Stéphanie Ragot(Université de Tours)
Cited by 104
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520